In conjunction with
26.2 with Donna - The National Marathon to Fight Breast Cancer www.breastcancermarathon.com

What you will learn:

• Optimism in the predictive role of molecular targeted therapy and associated genetic markers
  
• Genomic decision making approaches for making treatment choices with adjuvant hormonal therapy
  
• Molecular signatures for assessing clinical features of breast cancer using gene microarray studies
  
• Challenges related to the rational use of molecular targeting agents
  
• Moving from diagnosis and treatment of breast cancer to healthy survivorship
  
• Promising pipeline drug development and current clinical trials